Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload - Nolte, Florian; Schumann, Christiane; Hofmann, Wolf-Karsten (Annals of hematology, 2013)
Gesehen am: 11.02.2015